What is HumanFirst?
HumanFirst is dedicated to building the essential operational infrastructure required to support decentralized clinical trials and distributed care models within patients' homes. The company's core mission is to alleviate human suffering by deeply understanding the needs of those who interact with its products, whether as users, creators, or beneficiaries. This focus on human-centric design and operational efficiency positions HumanFirst at the forefront of transforming healthcare delivery.
How much funding has HumanFirst raised?
HumanFirst has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2021): $12M with participation from SV Angel, Arkitekt Ventures, Boost VC, Lux Capital, Village Global, and Maverick Ventures
Key Investors in HumanFirst
SV Angel
SV Angel is a long-term investment firm dedicated to supporting founders in creating impactful businesses. They prioritize building strong partnerships by advocating for founders and providing essential resources, strategic insights, and a vast network to help companies scale.
Arkitekt Ventures
Arkitekt Ventures is an early stage venture fund that focuses on innovative healthcare delivery models and the application of frontier technology in medicine. The company invests in visionary entrepreneurs who are dedicated to transforming advanced science and technology into solutions that significantly enhance human health.
Boost VC
Boost VC is a leading investor in deep tech, focusing on emerging and frontier categories. They provide funding primarily through Pre-Seed rounds with investments averaging $500k, as well as offering a $50k Fellowship check for early-stage startups.
What's next for HumanFirst?
With a recent major strategic investment, HumanFirst is poised for significant expansion and innovation in the healthcare technology sector. The company's focus on decentralized trials and distributed care aligns with the growing trend towards patient-centric healthcare solutions. This strategic financing will likely fuel advancements in their operational infrastructure, enabling broader adoption and impact. Future developments may include enhanced platform capabilities, strategic partnerships to expand reach, and further integration of technology to streamline remote patient monitoring and trial management, ultimately aiming to reduce healthcare costs and improve patient outcomes.
See full HumanFirst company page
